Trade Summary

3 days ago, Onyia Jude, serving as Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 11,000 shares at $155.53 per share, for a total transaction value of $1,710,865.20. Following this transaction, Onyia Jude now holds 25,846 shares of NBIX.

This sale represents a 29.85% decrease in Onyia Jude's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 27, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 29, 2026 at 6:09 PM ET, 2 days after the trade was made.

NEUROCRINE BIOSCIENCES INC operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.